BioCryst Pharmaceuticals, Inc. (BMV:BCRX)
159.50
-38.00 (-19.24%)
At close: Aug 18, 2025
BioCryst Pharmaceuticals Market Cap
BioCryst Pharmaceuticals has a market cap or net worth of 28.11 billion as of October 10, 2025. Its market cap has decreased by -8.22% in one year.
Market Cap
28.11B
Enterprise Value
36.99B
Revenue
10.51B
Ranking
n/a
PE Ratio
n/a
Stock Price
159.50
Market Cap Chart
Since March 4, 1994, BioCryst Pharmaceuticals's market cap has increased from 69.93M to 28.11B, an increase of 40,097.16%. That is a compound annual growth rate of 20.88%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 10, 2025 | 28.11B | -13.40% |
Dec 31, 2024 | 32.46B | 56.49% |
Dec 29, 2023 | 20.74B | -50.32% |
Dec 30, 2022 | 41.75B | -18.29% |
Dec 31, 2021 | 51.09B | 95.19% |
Dec 31, 2020 | 26.17B | 161.10% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Wal-Mart de México | 977.63B |
Grupo Financiero Banorte | 487.15B |
Industrias Peñoles | 311.08B |
Arca Continental | 305.19B |
GMéxico Transportes | 155.61B |
FIBRA Prologis | 114.55B |
Fibra UNO | 100.99B |
Promotora y Operadora de Infraestructura, S. A. B. de C. V. | 96.55B |